Evidence for the causal role of endogenous interferon-α/β in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms

Clinical and Experimental Metastasis

Volumn 19, Issue 7, 2002, Pages 609-615

  McCarty, Marya F ^a   Bielenberg, Diane ^a   Donawho, Cherrie ^a   Bucana, Corazon D ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Carcinogenesis; Gelfoam sponges; Interferon; Metastasis

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; GELATINASE B; GELFOAM; INTERFERON RECEPTOR; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; DOWN REGULATION; GENE MUTATION; INHIBITION KINETICS; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; REGULATORY MECHANISM; SKIN TUMOR; TUMOR GROWTH; ULTRAVIOLET B RADIATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; CARCINOGENICITY TESTS; FEMALE; INTERFERON-ALPHA; INTERFERON-BETA; LUNG NEOPLASMS; MELANOMA; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; SKIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 0036457022     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020923326441     Document Type: Article

References (36)

1. Fidler IJ. Cancer biology: Invasion and metastasis. In Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds): Clinical Oncology, 2nd Edition. New York: Churchill Livingstone 2000; 29-53.
2. Fidler IJ, Yano S, Zhang R et al. The seed and soil hypothesis: Vascularization and brain metastases. Lancet 2002; 3: 53-7.
3. Fidler IJ, Singh RK, Yoneda J et al. Critical determinants of neoplastic angiogenesis. Cancer J Sci Am 2000; 6: S225-36.
4. Volpert OV, Lawler J, Bouck NP. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sci USA 1998; 95: 6343-8.
5. Streit M, Velasco P, Brown LF et al. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 1999; 155: 441-52.
6. O'Reilly MS, Boehm T, Shing Y et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
7. Stark GR, Kerr IM, Williams BR et al. How cells respond to interferons. Ann Rev Biochem 1998; 67: 227-64.
8. Gresser I. On the varied biologic effects of interferon. Cell Immunol 1977; 34: 406-15.
9. Clemens MJ, McNurlan MA. Regulation of cell proliferation and differentiation by interferons. Biochem J 1985; 226: 345-60.
10. Haque SJ, Williams BR. Signal transduction in the interferon system. Semin Oncol 1998; 25: 14-22.
11. Takaoka A, Mitani Y, Suemori H et al. Cross talk between interferon-γ and -α/β signaling components in caveola membrane domains. Science 2000; 288: 2357-60.
12. Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 1987; 47: 5155-61.
13. Bielenberg DR, Fidler IJ, Bucana CD. Constitutive expression of interferon beta in differentiated epithelial cells exposed to environmental stimuli. Cancer Biother Radiopharm 1998; 13: 375-82.
14. De Maeyer-Guignard J, De Maeyer E. Immunomodulation by interferons: Recent developments. Interferon 1985; 6: 69-91.
15. Singh RK, Gutman M, Bucana CD et al. Interferons alpha and beta downregulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 1995; 92: 4562-6.
16. Singh RK, Gutman M, Llansa N, Fidler IJ. Interferon-β prevents the upregulation of interleukin-8 expression in human melanoma cells. J Interferon Cytokine Res 1996; 16: 577-84.
17. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J. Downregulation of interleukin 8 gene expression in human fibroblasts: Unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci USA 1992; 89: 9049-53.
18. Kato N, Nawa A, Tamakoshi K et al. Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon-β. Am J Obstet Gynecol 1995; 172: 601-6.
19. Mintzer RJ, Croze E, Rubanyi GM et al. Differential effects of IFN-β1b on the proliferation of human vascular smooth muscle and endothelial cells. J Interferon Cytokine Res 1998; 18: 939-45.
20. Bielenberg DR, Bucana CD, Sanchez R et al. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-β. Int J Oncol 1999; 14: 401-8.
21. Wineland M, Ahearne P, Bielenberg D et al. Melanoma-induced epidermal hyperplasia increases angiogenesis of the lesion Proc Am Assoc Cancer Res 1998; 39: 375-6 (Abstr).
22. Kuniyasu H, Yasui W, Shinohara H et al. Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 2000; 157: 1523-35.
23. Huang S, Hendriks W, Althage A et al. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259: 1742-5.
24. Muller U, Steinhoff U, Reis LF et al. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918-21.
25. Steinhoff U, Muller U, Schertler A et al. Antiviral protection by vesicular stomatitis virus-specific antibodies in α/β interferon receptor-deficient mice. J Virol 1995; 69: 2153-8.
26. van den Broek MF, Muller U, Huang S et al. Immune defense in mice lacking type I and/or type II interferon receptors. Immunol Rev 1995; 148: 5-18.
27. Donawho CK, Wolf P, Kripke ML. Enhanced development of murine melanoma in UV-irradiated skin: UV dose response, waveband dependence, and relation to inflammation. Melanoma Res 1994; 4: 93-100.
28. Kozlowski JM, Hart IR, Fidler IJ et al. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst 1984; 72: 913-7.
29. McCarty MF, Baker CH, Bucana CD, Fidler IJ. Quantitative and qualitative in vivo angiogenesis assay. Int J Oncol 2002; 21: 5-10.
30. Weidner N, Semple JP, Welch WR et al. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
31. Eggermont AM. The role interferon-alpha in malignant melanoma remains to be defined. Eur J Cancer 2001; 37: 2147-53.
32. Kimyai-Asadi A, Usman A. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: The need for more evidence. J Am Acad Dermatol 2000; 43: 708-11.
33. Garbe C, Krasagakis K. Effects of interferons and cytokines on melanoma cells. J Invest Dermatol 1993; 100: 239S-44S.
34. Bielenberg DR, Bucana CD, Sanchez R et al. Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 1998; 111: 864-72.
35. Bolontrade MF, Stern MC, Binder RL et al. Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis 1998; 19: 2107-13.
36. Larcher F, Robles AI, Duran H et al. Upregulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res 1996; 56: 5391-6.